Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-250-0 | CAS number: 104-90-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Several acute toxicity studies were carried out, with key studies available for all relevant routes. In addition, two supporting studies assessed acute oral toxicity. In a study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) the LD50 oral was determined to be 710 mg/kg bw. In a study similar or equivalent to EU Method B.2 and OECD Guideline 403 (Acute Inhalation Toxicity) the LC50 inhalation was determined 2.67 mg/L. In a study similar or equivalent to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity) the LD50 dermal was determined 1000 mL/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Young rats
- Weight at study initiation: 200 - 300 g
- Fasting period before study: 24 hours
- Housing: Common cage
- Diet: Ad libitum
- Water: Ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED:
- 4.0 mL/kg bw - Doses:
- 250, 500, 640, 800, 1000, 2000, 4000 mg/kg bw.
- No. of animals per sex per dose:
- 5 male, 5 female
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Daily observations
- Necropsy of survivors performed: No
- Other examinations performed: None. - Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- 250 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- 250 mg/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 710 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 470 - 1 040
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 710 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 470 - 1 040
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 710 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 470 - 1 040
- Sex:
- male
- Dose descriptor:
- LD100
- Effect level:
- <= 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD100
- Effect level:
- <= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- On day one following dosing mortality was observed for all animals (5/5) of the high dose group (4000 mg/kg bw), three animals of the 2000 mg/kg bw and one animal each of the 1000, 800 and 640 mg/kg bw dose group. On day two of the observation period mortality was observed for two animals of the 2000 mg/kg bw and three animals of the 1000 mg/kg bw dose group. On day four one animal each of the 800 and 500 mg/kg bw dose groups were found dead. Following the 14 day observation period all animals (5/5) of the low dose group (250 mg/kg bw), 4/5 of the 500 and 600 mg/kg bw dose groups, 1/5 of the 800 mg/kg bw dose group and 0/5 of the 2000 and 4000 mg/kg bw dose groups survived.
- Clinical signs:
- other: Male animals dosed at 250 mg/kg bw and 500 mg/kg bw were languid with unkempt coats and nasal hemorrhage. Nasal hemorrhage and lethargy accompanied unkempt coats were observed in male animals at 640 mg/kg bw and 800 mg/kg bw. Male survivors appeared norma
- Gross pathology:
- Not determined.
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an acute oral toxicity study groups of fasted young albino rats (5 male/5 female per dose group) were given a single oral dose (gavage) of 250, 500, 640, 800, 1000, 2000, 4000 mg/kg bw and observed daily for 14 days. The obtained oral LD50 for males and females was 710 mg/kg bw (95% C.I. 470 – 1040 mg/kg bw). The LD0 obtained was 250 mg/kg bw and the LD100 was 2000 mg/kg bw.
- Executive summary:
A study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) was carried out. Groups of fasted young albino rats (5 male/5 female) were given a single oral dose (gavage) of 250, 500, 640, 800, 1000, 2000, 4000 mg/kg bw. The animals were observed daily for 14 days thereafter. The obtained oral LD50 for males and females was 710 mg/kg bw (95% C.I. 470 – 1040 mg/kg bw). The LD0 obtained was 250 mg/kg bw and the LD100 was 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 710 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- female
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 4 h
- Control animals:
- not specified
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- 2.67 mg/L air
- Exp. duration:
- 4 h
- Interpretation of results:
- toxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an acute inhalation toxicity study with rats a 4 h LC50 of 2.67 mg/L was determined.
- Executive summary:
A study similar or equivalent to EU Method B.2 and OECD Guideline 403 (Acute Inhalation Toxicity) was carried out. Rats were dosed for 4 hours. An LC50 of 2.67 mg/L was revealed.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 2.67 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Control animals:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 1 000 mg/kg bw
- Based on:
- not specified
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an acute dermal toxicity study with rabbits a LD50 of 1000 mg/kg bw was determined.
- Executive summary:
A study similar or equivalent to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity) was carried out. Rabbits were administered a single dermal dose. An LD50 of 1000 mg/kg bw was revealed.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 000 mg/kg bw
Additional information
Acute oral toxicity
A study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) was carried out. Groups of fasted young albino rats (5 male/5 female) were given a single oral dose (gavage) of 250, 500, 640, 800, 1000, 2000, 4000 mg/kg bw. The animals were observed daily for 14 days thereafter. The obtained oral LD50 for males and females was 710 mg/kg bw (95% C.I. 470 – 1040 mg/kg bw). The LD0 obtained was 250 mg/kg bw and the LD100 at 2000 mg/kg bw.
Support - Acute oral toxicity
A study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) was carried out. Groups of fasted Sprague Dawley-derived rats of the Crl :CD(WI)BR strain (5 male/5 female per dose group) were given a single oral dose (gavage) of 730, 1020, 1430, 1620, 1810, 2000 mg/kg bw and observed daily for 14 days. The obtained oral LD50 for all animals was 1737 mg/kg bw (95 % CL 1640-1839), for males only 1697 mg/kg bw (95 % CL 1484-1914) and females only 1797 mg/kg bw (95% fiducial limits could not be calculated). The LD0 obtained for males was 1020 mg/kg bw and 1620 mg/kg bw for females. The LD100 obtained for males and females was < 2000 mg/kg bw.
Support - Acute oral toxicity
A study similar or equivalent to EU Method B.1 and OECD Guideline 401 (Acute toxicity oral) was carried out. Groups of fasted Tylers Original Mice (5 male/5 female per dose group) were given a single oral dose (gavage) of 200, 400, 600, 800, and 1000 mg/kg bw and observed daily for 14 days. The obtained oral LD50 was620mg/kg bw (95 % CL 516-744).
Key - Acute inhalation toxicity
A study similar or equivalent to EU Method B.2 and OECD Guideline 403 (Acute Inhalation Toxicity) was carried out. Rats were dosed for 4 hours. An LC50 of 2.67 mg/L was revealed.
Key- Acute dermal toxicity
A study similar or equivalent to EU Method B.3 and OECD Guideline 402 (Acute Dermal Toxicity) was carried out. Rabbits were administered a single dermal dose. An LD50 of 1000 mL/kg bw was determined.
Justification for classification or non-classification
Based on the data available the substance is classified and labeled according to Regulation 1272/2008/EEC (CLP) as Acute toxicity category 4, Oral H302 Harmful if swallowed, acute toxicity category 3, Dermal H311 Toxic in contact with skin, acute toxicity category 3, Inhalation H331 Toxic if inhaled and Xn harmful, R20/21/22 Harmful by inhalation, in contact with skin and if swallowed according to Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.